Company Filing History:
1 out of 203 
1 out of 634 
Years Active: 2025
Title: Kevin Jay Rodzinak: Innovator in Pharmaceutical Compounds
Introduction
Kevin Jay Rodzinak is an accomplished inventor based in Moody, Alabama. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that address serious genetic disorders. His work focuses on innovative solutions that can potentially improve the lives of individuals affected by various health conditions.
Latest Patents
Rodzinak holds a patent for "Uracil derivatives for stimulating read-through of premature termination codons." This patent involves substituted uracil compounds and pharmaceutical compositions that can treat disorders associated with premature termination codons. These disorders include cystic fibrosis, Duchenne muscular dystrophy, and several others. The patent aims to provide methods for treating these conditions using the developed compounds.
Career Highlights
Throughout his career, Rodzinak has worked with notable organizations such as Southern Research Institute and the UAB Research Foundation. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of Rodzinak's coworkers include Terry Smalley and Robert Hunter. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.
Conclusion
Kevin Jay Rodzinak's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving health outcomes for individuals with genetic disorders. His work exemplifies the impact of dedicated inventors in the medical field.